Organicell Regenerative Medicine, Inc.

Share · US09074L1052 (OTC)

No Price

n/a

Company Profile for Organicell Regenerative Medicine, Inc. Share

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

Get up to date insights from finAgent about Organicell Regenerative Medicine, Inc.

Company Data

Name Organicell Regenerative Medicine, Inc.

Company Organicell Regenerative Medicine, Inc.

Website http://www.organicell.com

Primary Exchange

UTC

ISIN US09074L1052

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Albert Mitrani

Country United States of America

Currency USD

Employees 0,0 T

Address 4045 Sheridan Avenue, 33140 Miami

IPO Date 2022-01-31

Ticker Symbols

Name	Symbol
Over The Counter	BPSR

More Shares

Investors who hold Organicell Regenerative Medicine, Inc. also have the following shares in their portfolio:

AEROP.PARIS 24/31 Bond

DZ BANK CLN E.8732 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog